Charles A. Deignan net worth and biography

Charles Deignan Biography and Net Worth

Mr. Deignan has served as our Chief Financial Officer since 2012. He is responsible for all financial and administrative aspects of the company including financing, business planning and analysis, investor relations, tax, accounting, treasury, human resources, and information technology. Mr. Deignan has overseen multiple partnering agreements, private financings and public equity fundraising, including Clearside’s initial public offering and subsequent completion of various equity transactions and debt facilities. From 2009 to 2011, Mr. Deignan was Vice President of Finance and Administration for Salutria Pharmaceuticals. Previously, from 1999 to 2009, Mr. Deignan served in a number of roles with AtheroGenics, Inc., a publicly held biopharmaceutical company, including as its Vice President of Finance and Administration. Prior to that, he held management positions at AAIPharma, Inc. and Schering-Plough. Mr. Deignan received his B.S. degree in Business Administration from Boston University.

What is Charles A. Deignan's net worth?: The estimated net worth of Charles A. Deignan is at least $9.15 thousand as of January 19th, 2024. Mr. Deignan owns 25,644 shares of Clearside Biomedical stock worth more than $9,155 as of December 5th. This net worth approximation does not reflect any other assets that Mr. Deignan may own. Additionally, Mr. Deignan receives an annual salary of $568,680.00 as CFO at Clearside Biomedical. Learn More about Charles A. Deignan's net worth.
How old is Charles A. Deignan?: Mr. Deignan is currently 60 years old. There are 5 older executives and no younger executives at Clearside Biomedical. The oldest executive at Clearside Biomedical is Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D., President, CEO & Director, who is 72 years old. Learn More on Charles A. Deignan's age.
What is Charles A. Deignan's salary?: As the CFO of Clearside Biomedical, Inc., Mr. Deignan earns $568,680.00 per year. The highest earning executive at Clearside Biomedical is Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D., President, CEO & Director, who commands a salary of $836,150.00 per year. Learn More on Charles A. Deignan's salary.
How do I contact Charles A. Deignan?: The corporate mailing address for Mr. Deignan and other Clearside Biomedical executives is 900 NORTH POINT PARKWAY SUITE 200, ALPHARETTA GA, 30005. Clearside Biomedical can also be reached via phone at (678) 270-3631 and via email at [email protected]. Learn More on Charles A. Deignan's contact information.
Has Charles A. Deignan been buying or selling shares of Clearside Biomedical?: Charles A. Deignan has not been actively trading shares of Clearside Biomedical in the last ninety days. Most recently, Charles A. Deignan sold 860 shares of the business's stock in a transaction on Friday, January 19th. The shares were sold at an average price of $19.20, for a transaction totalling $16,512.00. Following the completion of the sale, the chief financial officer now directly owns 25,644 shares of the company's stock, valued at $492,364.80. Learn More on Charles A. Deignan's trading history.
Who are Clearside Biomedical's active insiders?: Clearside Biomedical's insider roster includes Richard Burke (Director), Thomas Ciulla (Insider), Charles Deignan (CFO), George Lasezkay (CEO), and Bradford Whitmore (Major Shareholder). Learn More on Clearside Biomedical's active insiders.
Are insiders buying or selling shares of Clearside Biomedical?: In the last year, Clearside Biomedical insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $13,800.00. The most recent insider tranaction occured on February, 24th when Director Clay Thorp bought 1,000 shares worth more than $13,800.00. Insiders at Clearside Biomedical own 6.7% of the company. Learn More about insider trades at Clearside Biomedical.
Information on this page was last updated on 2/24/2025.

Charles A. Deignan Insider Trading History at Clearside Biomedical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/19/2024	Sell	860	$19.20	$16,512.00	25,644
1/19/2023	Sell	935	$22.50	$21,037.50	24,231
1/19/2022	Sell	588	$31.35	$18,433.80
9/21/2021	Sell	186	$96.15	$17,883.90
6/21/2021	Sell	195	$65.55	$12,782.25	21,283
11/12/2019	Buy	500	$17.10	$8,550.00	13,590
3/15/2019	Buy	666	$20.40	$13,586.40	5,090
3/23/2018	Buy	33	$176.85	$5,836.05	4,423
8/14/2017	Buy	66	$106.05	$6,999.30	4,353

Charles A. Deignan Buying and Selling Activity at Clearside Biomedical

Clearside Biomedical Company Overview

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Today's Range

Now: $0.36

$0.37

$0.59

50 Day Range

MA: $3.24

$0.36

$4.40

2 Week Range

Now: $0.36

$0.37

$17.10

Volume

2,768,773 shs

Average Volume

152,333 shs

Market Capitalization

$1.87 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.04

Charles Deignan Biography and Net Worth

What is Charles A. Deignan's net worth?

How old is Charles A. Deignan?

What is Charles A. Deignan's salary?

How do I contact Charles A. Deignan?

Has Charles A. Deignan been buying or selling shares of Clearside Biomedical?

Who are Clearside Biomedical's active insiders?

Are insiders buying or selling shares of Clearside Biomedical?